Enin I P, Baturin V A, Shchetinin E V, Karpov V P, Enin I V
Vestn Otorinolaringol. 2013(4):21-2.
The objective of the present work was to develop the standardized approaches to pharmacotherapy of chronic tonsillitis based on the data of regional specificity of the tonsillar microflora. The methods of investigations included the study of throat swabs obtained from 668 patients presenting with various forms of chronic tonsillitis (CT). Half of these patients were shown to be infected with Streptococcus pyogenes and 24.5% with Mycoplasma pneumoniae. The presence of concomitant pathology of the respiratory and digestive tracts in the patients with CT increases the probability of identification of enterobacteria, enteroccocci, and staphylococci in combination with streptococci and mycoplasmas. It is concluded that the choice of antibacterial therapy should be based on the results of analysis of the aggravated medical history and bacteriological diagnostics including the isolation of all putative pathogens and examination of their susceptinility to antibacterial agents.
本研究的目的是根据扁桃体微生物群区域特异性的数据，开发慢性扁桃体炎药物治疗的标准化方法。研究方法包括对668例患有各种形式慢性扁桃体炎（CT）的患者的咽拭子进行研究。这些患者中有一半被证明感染了化脓性链球菌，24.5%感染了肺炎支原体。慢性扁桃体炎患者呼吸道和消化道合并病变的存在增加了在链球菌和支原体的同时鉴定肠杆菌、肠球菌和葡萄球菌的可能性。得出的结论是，抗菌治疗的选择应基于对加重病史和细菌学诊断结果的分析，包括分离所有假定的病原体并检测它们对抗菌药物的敏感性。
